Skip to content

Published through 2026-11-18 15:16 UTC · Automated cloud publishing.

Vision Monday — Business·· 10 h agoEditorial score57

Newton’s Neurolens N3 Receives EU MDR CE Marking for European Commercialization

Newton’s Neurolens N3 Receives CE Mark, Clearing Path for European Commercialization

AI summary

Newton, Inc. announced that its Neurolens N3 measurement system has received CE marking under the European Union Medical Device Regulation (MDR), issued by Intertek Medical Notified Body AB. This certification clears the device for commercialization across the European Union and European Economic Area, joining existing markets in the U.S. and Canada. The N3 uses eye-tracking technology to provide objective ocular alignment data at distance and near, enabling eyecare professionals to prescribe Neurolens Contoured Prism lenses designed to relieve symptoms such as headaches and motion sickness associated with ocular misalignment. Newton expects to introduce the technology to patients in its first European markets in 2027.

Source:Vision Monday — Business · visionmonday.com